TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells.

MLA

Moniri, M. R., et al. “TRAIL-Engineered Pancreas-Derived Mesenchymal Stem Cells: Characterization and Cytotoxic Effects on Pancreatic Cancer Cells.” Cancer Gene Therapy, vol. 19, no. 9, Sept. 2012, pp. 652–58. EBSCOhost, https://doi.org/10.1038/cgt.2012.46.

APA

Moniri, M. R., Sun, X.-Y., Rayat, J., Dai, D., Ao, Z., He, Z., Verchere, C. B., Dai, L.-J., & Warnock, G. L. (2012). TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells. Cancer Gene Therapy, 19(9), 652–658. https://doi.org/10.1038/cgt.2012.46

Chicago

Moniri, M R, X-Y Sun, J Rayat, D Dai, Z Ao, Z He, C B Verchere, L-J Dai, and G L Warnock. 2012. “TRAIL-Engineered Pancreas-Derived Mesenchymal Stem Cells: Characterization and Cytotoxic Effects on Pancreatic Cancer Cells.” Cancer Gene Therapy 19 (9): 652–58. doi:10.1038/cgt.2012.46.